The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity
Open accessAbstract
Endothelial cell–cell junctions regulate vascular permeability, vasculogenesis, and angiogenesis. Familial cerebral cavernous malformations (CCMs) in humans result from mutations of CCM2 (malcavernin, OSM, MGC4607), PDCD10 (CCM3), or KRIT1 (CCM1), a Rap1 effector which stabilizes endothelial cell–cell junctions. Homozygous loss of KRIT1 or CCM2 produces lethal vascular phenotypes in mice and zebrafish. We report that the physical interaction of KRIT1 and CCM2 proteins is required for endothelial cell–cell junctional localization, and lack of either protein destabilizes barrier function by sustaining activity of RhoA and its effector Rho kinase (ROCK). Protein haploinsufficient Krit1+/− or Ccm2+/− mouse endothelial cells manifested increased monolayer permeability in vitro, and both Krit1+/− and Ccm2+/− mice exhibited increased vascular leak in vivo, reversible by fasudil, a ROCK inhibitor. Furthermore, we show that ROCK hyperactivity occurs in sporadic and familial human CCM endothelium as judged by increased phosphorylation of myosin light chain. These data establish that KRIT1–CCM2 interaction regulates vascular barrier function by suppressing Rho/ROCK signaling and that this pathway is dysregulated in human CCM endothelium, and they suggest that fasudil could ameliorate both CCM disease and vascular leak.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gavard, J., & Gutkind, J. S. (2006) · Nature Cell Biology · doi:10.1038/ncb1486 · Cited by 1,018
Cytoskeletal regulation of pulmonary vascular permeability
Dudek, S. M., & Garcia, J. G. N. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.91.4.1487 · Cited by 985
Rho Kinases in Cardiovascular Physiology and Pathophysiology
Loirand, G., Guérin, P., & Pacaud, P. (2006) · Circulation Research · doi:10.1161/01.res.0000201960.04223.3c · Cited by 547
Rho-Kinase Is an Important Therapeutic Target in Cardiovascular Medicine
Shimokawa, H., & Takeshita, A. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000176193.83629.c8 · Cited by 480
Rho and Rac but not Cdc42 regulate endothelial cell permeability
Wójciak-Stothard, B., Potempa, S., Eichholtz, T., & Ridley, A. J. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.7.1343 · Cited by 465
Smooth muscle cell calcium activation mechanisms
Berridge, M. J. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.160440 · Cited by 408
Sahoo, T., Johnson, E. W., Thomas, J. W., Kuehl, P. M., Jones, T. L., Dokken, C. G., Touchman, J. W., Gallione, C. J., Lee-Lin, S.-Q., Kosofsky, B., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.12.2325 · Cited by 382
Rac–MEKK3–MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock
Uhlik, M. T., Abell, A. N., Johnson, N. L., Sun, W., Cuevas, B. D., Lobel-Rice, K. E., Horne, E. A., Dell'Acqua, M. L., & Johnson, G. L. (2003) · Nature Cell Biology · doi:10.1038/ncb1071 · Cited by 378
The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases
Whitehead, K. J., Chan, A. C., Navankasattusas, S., Koh, W., London, N. R., Ling, J., Mayo, A. H., Drakos, S. G., Jones, C. A., Zhu, W., et al. (2009) · Nature Medicine · doi:10.1038/nm.1911 · Cited by 377
Cullere, X., Shaw, S. K., Andersson, L., Hirahashi, J., Luscinskas, F. W., & Mayadas, T. N. (2005) · Blood · doi:10.1182/blood-2004-05-1987 · Cited by 360
Applications for ROCK kinase inhibition
Olson, M. F. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.01.002 · Cited by 347
Liquori, C. L., Berg, M. J., Siegel, A. M., Huang, E., Zawistowski, J. S., Stoffer, T., Verlaan, D., Balogun, F., Hughes, L., Leedom, T. P., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/380314 · Cited by 345
Clatterbuck, R. E. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.71.2.188 · Cited by 324
KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell–cell junctions
Glading, A., Han, J., Stockton, R. A., & Ginsberg, M. H. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200705175 · Cited by 315
Self-citationEpac1 regulates integrity of endothelial cell junctions through VE‐cadherin
Kooistra, M. R. H., Corada, M., Dejana, E., & Bos, J. L. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.07.080 · Cited by 302
Hemorrhage From Cavernous Malformations of the Brain: Definition and Reporting Standards
Al-Shahi Salman, R., Berg, M. J., Morrison, L., & Awad, I. A. (2008) · Stroke · doi:10.1161/strokeaha.108.515544 · Cited by 302
Self-citationAkers, A. L., Johnson, E., Steinberg, G. K., Zabramski, J. M., & Marchuk, D. A. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn430 · Cited by 292
van Wetering, S., van Buul, J. D., Quik, S., Mul, F. P. J., Anthony, E. C., Klooster, J.-P. T., Collard, J. G., & Hordijk, P. L. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.9.1837 · Cited by 278
Zawistowski, J. S., Stalheim, L., Uhlik, M. T., Abell, A. N., Ancrile, B. B., Johnson, G. L., & Marchuk, D. A. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi256 · Cited by 254
Kleaveland, B., Zheng, X., Liu, J. J., Blum, Y., Tung, J. J., Zou, Z., Sweeney, S. M., Chen, M., Guo, L., Lu, M.-M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1918 · Cited by 248
Self-citationPhosphorylation of Claudin-5 and Occludin by Rho Kinase in Brain Endothelial Cells
Yamamoto, M., Ramirez, S. H., Sato, S., Kiyota, T., Cerny, R. L., Kaibuchi, K., Persidsky, Y., & Ikezu, T. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070076 · Cited by 241
An essential role for Rac1 in endothelial cell function and vascular development
Tan, W., Palmby, T. R., Gavard, J., Amornphimoltham, P., Zheng, Y., & Gui, J. S. (2008) · The FASEB Journal · doi:10.1096/fj.07-096438 · Cited by 227
Serebriiskii, I., Estojak, J., Sonoda, G., Testa, J. R., & Golemis, E. A. (1997) · Oncogene · doi:10.1038/sj.onc.1201268 · Cited by 215
Pagenstecher, A., Stahl, S., Sure, U., & Felbor, U. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn420 · Cited by 210
Patil, P. G., Carmena, J. M., Nicolelis, M. A. L., & Turner, D. A. (2004) · Neurosurgery · doi:10.1227/01.neu.0000126872.23715.e5 · Cited by 208
Whitehead, K. J., Plummer, N. W., Adams, J. A., Marchuk, D. A., & Li, D. Y. (2004) · Development · doi:10.1242/dev.01036 · Cited by 202
CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations
Voss, K., Stahl, S., Schleider, E., Ullrich, S., Nickel, J., Mueller, T. D., & Felbor, U. (2007) · Neurogenetics · doi:10.1007/s10048-007-0098-9 · Cited by 176
Pathobiology of Human Cerebrovascular Malformations: Basic Mechanisms and Clinical Relevance
Gault, J., Sarin, H., Awadallah, N. A., Shenkar, R., & Awad, I. A. (2004) · Neurosurgery · doi:10.1227/01.neu.0000440729.59133.c9 · Cited by 170
Self-citationRho and ROCK Signaling in VEGF‐Induced Microvascular Endothelial Hyperpermeability
SUN, H., BRESLIN, J. W., ZHU, J., YUAN, S. Y., & WU, M. H. (2006) · Microcirculation · doi:10.1080/10739680600556944 · Cited by 170
Rap1 GTPase Inhibits Leukocyte Transmigration by Promoting Endothelial Barrier Function
Wittchen, E. S., Worthylake, R. A., Kelly, P., Casey, P. J., Quilliam, L. A., & Burridge, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412595200 · Cited by 168
Wojciak-Stothard, B., Tsang, L. Y. F., & Haworth, S. G. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00361.2004 · Cited by 167
p21-activated Kinase Regulates Endothelial Permeability through Modulation of Contractility
Stockton, R. A., Schaefer, E., & Schwartz, M. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408877200 · Cited by 154
Self-citationProteomic Identification of the Cerebral Cavernous Malformation Signaling Complex
Hilder, T. L., Malone, M. H., Bencharit, S., Colicelli, J., Haystead, T., Johnson, G. L., & Wu, C. C. (2007) · Journal of Proteome Research · doi:10.1021/pr0704276 · Cited by 151
santaandvalentinepattern concentric growth of cardiac myocardium in the zebrafish
Mably, J. D., Chuang, L. P., Serluca, F. C., Mohideen, M.-A. P. K., Chen, J., & Fishman, M. C. (2006) · Development · doi:10.1242/dev.02469 · Cited by 149
Radiation-induced cavernomas of the brain.
Jain, R., Robertson, P. L., Gandhi, D., Gujar, S. K., Muraszko, K. M., & Gebarski, S. S. (2005) · PubMed Central · Cited by 135
Rolfe, B. E., Worth, N. F., WORLD, C., Campbell, J. H., & CAMPBELL, G. R. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.04.023 · Cited by 134
Intracellular signalling involved in modulating human endothelial barrier function*
van Hinsbergh, V. W. M., & Amerongen, G. P. V. N. (2002) · Journal of Anatomy · doi:10.1046/j.1469-7580.2002.00060.x · Cited by 130
Plummer, N. W., Gallione, C. J., Srinivasan, S., Zawistowski, J. S., Louis, D. N., & Marchuk, D. A. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63409-8 · Cited by 119
Yamashita, K., Kotani, Y., Nakajima, Y., Shimazawa, M., Yoshimura, S., Nakashima, S., Iwama, T., & Hara, H. (2007) · Brain Research · doi:10.1016/j.brainres.2007.04.013 · Cited by 118
Hogan, B. M., Bussmann, J., Wolburg, H., & Schulte‐Merker, S. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn142 · Cited by 116
Boulday, G., Blécon, A., Petit, N., Chareyre, F., García, L., Niwa‐Kawakita, M., Giovannini, M., & Tournier‐Lasserve, E. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.001263 · Cited by 115
Activation of Rho Kinase Isoforms in Lung Endothelial Cells during Inflammation
Mong, P. Y., & Wang, Q. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802811 · Cited by 108
Crose, L. E. S., Hilder, T. L., Sciaky, N., & Johnson, G. L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.c900009200 · Cited by 101
INTERACTION BETWEEN KRIT1 AND MALCAVERNIN
Zhang, J., Rigamonti, D., Dietz, H. C., & Clatterbuck, R. E. (2007) · Neurosurgery · doi:10.1227/01.neu.0000249268.11074.83 · Cited by 88
Attenuating Burn Wound Inflammatory Signaling Reduces Systemic Inflammation and Acute Lung Injury
Ipaktchi, K. R., Mattar, A., Niederbichler, A. D., Hoesel, L. M., Vollmannshauser, S., Hemmila, M. R., Su, G. L., Remick, D. G., Wang, S. C., & Arbabi, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.8065 · Cited by 81
Genetics of cerebral cavernous malformations
Plummer, N. W., Zawistowski, J. S., & Marchuk, D. A. (2005) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-005-0063-7 · Cited by 72
Petit, N., Blécon, A., Denier, C., & Tournier‐Lasserve, E. (2006) · Gene Expression Patterns · doi:10.1016/j.modgep.2005.11.001 · Cited by 70
Wilson, M. R., Goddard, M. E., O'Dea, K. P., Choudhury, S., & Takata, M. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00284.2006 · Cited by 65
Fong, B., Watson, P. H., & Watson, A. J. (2007) · BMC Developmental Biology · doi:10.1186/1471-213x-7-2 · Cited by 55
Reutershan, J., Stockton, R. A., Zarbock, A., Sullivan, G. W., Chang, D., Scott, D., Schwartz, M. A., & Ley, K. F. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200612-1822oc · Cited by 44
Self-citationSatoh, S.-I., Hitomi, A., Ikegaki, I., Kawasaki, K., Nakazono, O., Iwasaki, M., Mohri, M., & Asano, T. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.08.021 · Cited by 41
Multiple cerebral cavernous malformations associated with extracranial mesenchymal anomalies
Ardeshiri, A., Ardeshiri, A., Beiras-Fernández, A., Steinlein, O. K., & Winkler, P. (2007) · Neurosurgical Review · doi:10.1007/s10143-007-0111-7 · Cited by 22
Hyperosmotic Induction of Mitogen‐Activated Protein Kinase Scaffolding
Hilder, T. L., Malone, M. H., & Johnson, G. L. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)28017-6 · Cited by 17
Central Role of Rho Kinase in Lipopolysaccharide-Induced Platelet Capture on Venous Endothelium
Slotta, J. E., Braun, O. Ö., Menger, M. D., & Thorlacius, H. (2008) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e31816c3e81 · Cited by 10
Cited by
Blood-brain barrier dysfunction and recovery after ischemic stroke
Jiang, X., Andjelkovic, A. V., Zhu, L., Yang, T., Bennett, M. V. L., Chen, J., Keep, R. F., & Shi, Y. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.10.001 · Cited by 936
VE-Cadherin and Endothelial Adherens Junctions: Active Guardians of Vascular Integrity
Giannotta, M., Trani, M., & Dejana, E. (2013) · Developmental Cell · doi:10.1016/j.devcel.2013.08.020 · Cited by 854
“Recently, the Rap1 effector Krev interaction trapped protein1/cerebral cavernous malformation 1 (Krit-1/CCM1) protein has been proposed to be involved in Rap1-mediated regulation of Rho signaling (Glading et al., 2007; Glading and Ginsberg, 2010; Stockton et al., 2010).”
BackgroundVascular heterogeneity and specialization in development and disease
Potente, M., & Mäkinen, T. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.36 · Cited by 653
EndMT contributes to the onset and progression of cerebral cavernous malformations
Maddaluno, L., Rudini, N., Cuttano, R., Bravi, L., Giampietro, C., Corada, M., Ferrarini, L., Orsenigo, F., Papa, E., Boulday, G., et al. (2013) · Nature · doi:10.1038/nature12207 · Cited by 486
Junctional proteins of the blood-brain barrier: New insights into function and dysfunction
Stamatovic, S. M., Johnson, A. M., Keep, R. F., & Andjelkovic, A. V. (2016) · Tissue Barriers · doi:10.1080/21688370.2016.1154641 · Cited by 428
Metadata
- Authors
- Stockton, R. A., Shenkar, R., Awad, I. A., & Ginsberg, M. H.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2010-03-22
- Volume
- 207
- Issue
- 4
- Pages
- 881-896
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2171538469
- Cited by
- 351
- References
- 54
- FWCI
- 13.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.